| Dr Blondine Dieujuste, CRNA | |
|
10800 Midlothian Tpke Ste 265, North Chesterfield, VA 23235-4700 | |
| (804) 594-1392 | |
| Not Available |
| Full Name | Dr Blondine Dieujuste |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 10800 Midlothian Tpke Ste 265, North Chesterfield, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285216523 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cjw Medical Center | Richmond, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dogwood Anesthesia Providers Llc | 2769853084 | 133 |
News Archive
Roll Call: Billy Tauzin, the former Louisiana lawmaker, will leave his job as the president of the Pharmaceutical Research and Manufacturers of America next Wednesday, and part ways - for the first time in 18 years - with his trusty communications director, Ken Johnson. As Roll Call puts it, "The sun is setting on a K Street bromance." Tauzin is likely to start a lobbying firm with his son Tom or practice law in Texas, while Johnson will pursue other work. The two were said to be "attached at the hip" (Murray, 6/23).
The lowly appendix, long-regarded as a useless evolutionary artifact, won newfound respect two years ago when researchers at Duke University Medical Center proposed that it actually serves a critical function. The appendix, they said, is a safe haven where good bacteria could hang out until they were needed to repopulate the gut after a nasty case of diarrhea, for example.
Evotec AG today announced that it has achieved a milestone as part of its research alliance with Boehringer Ingelheim and will receive a payment of EUR 2.5 million. The milestone was achieved for the selection of a candidate compound for pre-development studies in an oncology programme.
British researchers have discovered a new way of detecting which breast cancer patients are going to respond best to chemotherapy that includes anthracycline antibiotics. The study has found that an abnormality on chromosome 17, called CEP17, is not only associated with a worse outcome for patients, but also that its presence is a highly significant indicator that the tumour will respond to anthracyclines. The research will be presented at the European Breast Cancer Conference (EBCC7) Thursday 25th March.
› Verified 3 days ago
| Entity Name | Dogwood Anesthesia Providers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982329900 PECOS PAC ID: 2769853084 Enrollment ID: O20230125000989 |
News Archive
Roll Call: Billy Tauzin, the former Louisiana lawmaker, will leave his job as the president of the Pharmaceutical Research and Manufacturers of America next Wednesday, and part ways - for the first time in 18 years - with his trusty communications director, Ken Johnson. As Roll Call puts it, "The sun is setting on a K Street bromance." Tauzin is likely to start a lobbying firm with his son Tom or practice law in Texas, while Johnson will pursue other work. The two were said to be "attached at the hip" (Murray, 6/23).
The lowly appendix, long-regarded as a useless evolutionary artifact, won newfound respect two years ago when researchers at Duke University Medical Center proposed that it actually serves a critical function. The appendix, they said, is a safe haven where good bacteria could hang out until they were needed to repopulate the gut after a nasty case of diarrhea, for example.
Evotec AG today announced that it has achieved a milestone as part of its research alliance with Boehringer Ingelheim and will receive a payment of EUR 2.5 million. The milestone was achieved for the selection of a candidate compound for pre-development studies in an oncology programme.
British researchers have discovered a new way of detecting which breast cancer patients are going to respond best to chemotherapy that includes anthracycline antibiotics. The study has found that an abnormality on chromosome 17, called CEP17, is not only associated with a worse outcome for patients, but also that its presence is a highly significant indicator that the tumour will respond to anthracyclines. The research will be presented at the European Breast Cancer Conference (EBCC7) Thursday 25th March.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Blondine Dieujuste, CRNA 2121 Fernbank Way, Dacula, GA 30019-2472 Ph: (678) 697-6565 | Dr Blondine Dieujuste, CRNA 10800 Midlothian Tpke Ste 265, North Chesterfield, VA 23235-4700 Ph: (804) 594-1392 |
News Archive
Roll Call: Billy Tauzin, the former Louisiana lawmaker, will leave his job as the president of the Pharmaceutical Research and Manufacturers of America next Wednesday, and part ways - for the first time in 18 years - with his trusty communications director, Ken Johnson. As Roll Call puts it, "The sun is setting on a K Street bromance." Tauzin is likely to start a lobbying firm with his son Tom or practice law in Texas, while Johnson will pursue other work. The two were said to be "attached at the hip" (Murray, 6/23).
The lowly appendix, long-regarded as a useless evolutionary artifact, won newfound respect two years ago when researchers at Duke University Medical Center proposed that it actually serves a critical function. The appendix, they said, is a safe haven where good bacteria could hang out until they were needed to repopulate the gut after a nasty case of diarrhea, for example.
Evotec AG today announced that it has achieved a milestone as part of its research alliance with Boehringer Ingelheim and will receive a payment of EUR 2.5 million. The milestone was achieved for the selection of a candidate compound for pre-development studies in an oncology programme.
British researchers have discovered a new way of detecting which breast cancer patients are going to respond best to chemotherapy that includes anthracycline antibiotics. The study has found that an abnormality on chromosome 17, called CEP17, is not only associated with a worse outcome for patients, but also that its presence is a highly significant indicator that the tumour will respond to anthracyclines. The research will be presented at the European Breast Cancer Conference (EBCC7) Thursday 25th March.
› Verified 3 days ago
Colleen Margaret Kienle, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10800 Midlothian Tpke, Suite 207, North Chesterfield, VA 23235 Phone: 804-594-2622 Fax: 804-594-0915 | |
Timothy D. Crawley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10800 Midlothian Tpke, Suite 265, North Chesterfield, VA 23235 Phone: 804-594-2622 Fax: 804-594-0915 | |
Kassie L Quinlevan, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10800 Midlothian Tpke, Suite 207, North Chesterfield, VA 23235 Phone: 804-594-2622 Fax: 804-594-0915 | |
Amy L. Harcum, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10800 Midlothian Tpke, Suite 265, North Chesterfield, VA 23235 Phone: 804-594-2622 Fax: 804-594-0915 | |
Megan Kelly, RN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10800 Midlothian Tpke, Suite 207, North Chesterfield, VA 23235 Phone: 804-594-2622 Fax: 804-594-0915 | |
Joseph Keaton Hoyle, RN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10800 Midlothian Tpke, Suite 207, North Chesterfield, VA 23235 Phone: 804-594-2622 Fax: 804-594-0915 | |
Nicole Carter, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10800 Midlothian Tpke, Suite 207, North Chesterfield, VA 23235 Phone: 804-594-2622 Fax: 804-594-0915 |